GANX stock news

GANX stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

4 wire items

2026-10-28 21:03:01 UTC#532602newconfirmednews

Gain Therapeutics appoints Jeanette Weidner as VP of Finance, principal financial and accounting officer

tradingviewimportance 0.30trust 0.80Gain Therapeutics, Inc. +0.10Jeanette Weidner +0.10OncoC4, Inc. 0+1 entities

2026-08-31 10:29:00 UTC#241823newconfirmednews

H.C. Wainwright & Co. maintains $8.00 price target on Gain Therapeutics (GANX)

dow_jonesimportance 0.30trust 0.70Gain Therapeutics, Inc. 0H.C. Wainwright & Co., LLC 0

2026-08-12 09:30:00 UTC#163970newconfirmednews

BTIG maintains $5.00 price target on Gain Therapeutics (GANX)

dow_jonesimportance 0.30trust 0.70Gain Therapeutics, Inc. 0BTIG, LLC 0

2026-08-11 11:13:12 UTC#158141newconfirmednews

Gain Therapeutics reports Q2 GAAP EPS of -$0.11, beating consensus estimates by $0.03

seeking alphaimportance 0.30trust 0.80Gain Therapeutics, Inc. +0.30